Cipla Q1 FY27 PAT falls 39% YoY on margin pressure

Ebitda Margin CompressionResults View source PDF Explain this filing

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹1415.90

prior close

₹1406.10

announcement price

In-mkt

timing

Nifty 100market-0.5%-0.9% vs market

Pharmaceuticals peers, median of 164sector-0.7%-0.8% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty 100 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

-0.9

15m

-0.7

30m

-1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5-0.5-0.9-0.7-0.8

Next day

-0.5-0.9+0.4-0.8+0.4

-0.1+0.1-0.1-0.1+0.0

+2.1-0.1+2.2-0.8+2.9

+4.1+0.9+3.2+0.0+4.1

+3.7+1.2+2.5-0.6+4.3

+3.1+3.2-0.1-0.3+3.4

15d

+2.9+2.0+0.9+2.4+0.5

+1.6+1.2+0.4+0.9+0.7

-2.5-1.8-0.6+4.0-6.5

-5.5-6.4+0.9-5.5-0.0

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Cipla Q1 FY27 consolidated revenue up 2.3% YoY at Rs 7,119 cr, but net profit fell 39% to Rs 786 cr from Rs 1,292 cr. Standalone PAT dropped 34% to Rs 862 cr. Total expenses jumped 14.7% as employee costs and depreciation rose, sharply compressing margins. Auditor changed to B S R & Co. LLP.

Likely market impact

Sharp profit decline despite modest revenue growth; weak operating performance may weigh on stock.